Gianmarco Sarto
Latina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Giant Thrombosed Coronary Aneurysm Causing Recurrent Ischemic Events: Insights From Multimodality Imaging and Surgical Management.
Journal: JACC. Case reports
Published: April 20, 2026
SGLT2 inhibitors after transcatheter aortic valve implantation: a systematic review and exploratory meta-analysis.
Journal: International journal of cardiology. Heart & vasculature
Published: March 24, 2026
Transcatheter management of cardiogenic shock in severe aortic stenosis.
Journal: Frontiers in cardiovascular medicine
Published: February 03, 2026
SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis.
Journal: JACC. Advances
Published: January 02, 2026
Magnitude of Blood Pressure Reduction in Response to Levosimendan Infusion Independently Predicts In-Hospital Mortality in Patients With Acute Heart Failure.
Journal: Journal of cardiovascular pharmacology
Published: November 07, 2025
Optimizing selection of P2Y12 inhibiting therapy: clopidogrel, prasugrel or ticagrelor.
Journal: Expert opinion on pharmacotherapy
Published: October 22, 2025
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism.
Journal: Redox biology
Published: October 06, 2025
Bridging Dermatology and Cardiology: The Link between Skin Lesions and Cardiovascular Risk.
Journal: Current cardiology reviews
Published: August 20, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: July 27, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Journal: Journal of the American College of Cardiology
Published: July 23, 2025
Pharmacological reactivation of autophagic flux by natural compounds or synthetic cell-permeable peptide prevents doxorubicin-induced cardiomyopathy.
Journal: Basic research in cardiology
Published: July 10, 2025
Last Updated: 09/26/2026